Annual report pursuant to Section 13 and 15(d)

Provision for Income Taxes - Additional Information (Detail)

v3.22.0.1
Provision for Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2021
Aug. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Income Taxes Disclosure [Line Items]        
Operating loss carryforwards, limitations on use     Net federal operating loss carryforwards generated after January 1, 2018 may be carried forward indefinitely, subject to the 80% taxable income limitation on the utilization of the carryforwards.  
Research and development credit carry forward     $ 4,632 $ 3,193
Tax rate     (4.04%) (0.16%)
Decrease in income tax provision     $ 2,257  
Unrecognized tax benefits netted against its deferred tax assets within other assets     1,111 $ 720
Unrecognized tax benefits if recognized     1,015  
Israeli [Member]        
Income Taxes Disclosure [Line Items]        
Tax rate 23.00% 12.00%    
Federal [Member]        
Income Taxes Disclosure [Line Items]        
Operating loss carry forward     $ 217,754  
Operating loss carry forwards expiration year     2034  
Research and development credit carry forward     $ 3,636  
Research and development credit expiration year     2036  
State [Member]        
Income Taxes Disclosure [Line Items]        
Operating loss carry forward     $ 135,075  
Operating loss carry forwards expiration year     2022  
Research and development credit carry forward     $ 2,545